Abera Bioscience AB

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0015245097
SEK
6.35
-0.1 (-1.55%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Expres2ion Biotech Holding AB
Xintela AB
Phase Holographic Imaging AB
AlzeCure Pharma AB
Lipum AB
Active Biotech AB
SenzaGen AB
Bioextrax AB
Toleranzia AB
Abera Bioscience AB
Biosergen AB

Why is Abera Bioscience AB ?

Icon
Unrated Stock - No Analysis Available
stock-recommendationReal-Time Research Report

Verdict Report

Icon
No Data Found
Icon
No Data Found
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
-100.00%
EBIT Growth (5y)
5.96%
EBIT to Interest (avg)
-14.38
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.63
Sales to Capital Employed (avg)
0
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
15.35
EV to EBIT
-6.64
EV to EBITDA
-6.69
EV to Capital Employed
-111.28
EV to Sales
NA
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-11.55%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
Bearish
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

19What is working for the Company
OPERATING CASH FLOW(Y)

Highest at SEK -0.15 MM

ROCE(HY)

Highest at -8.13%

PRE-TAX PROFIT(Q)

At SEK 0.01 MM has Grown at 103.34%

NET PROFIT(Q)

At SEK 0.01 MM has Grown at 103.34%

RAW MATERIAL COST(Y)

Fallen by 0% (YoY

0What is not working for the Company
NO KEY NEGATIVE TRIGGERS

Here's what is working for Abera Bioscience AB

Operating Cash Flow
Highest at SEK -0.15 MM and Grown
In each year in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (SEK MM)

Pre-Tax Profit
At SEK 0.01 MM has Grown at 103.34%
Year on Year (YoY)
MOJO Watch
Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (SEK MM)

Net Profit
At SEK 0.01 MM has Grown at 103.34%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is very positive

Net Profit (SEK MM)

Raw Material Cost
Fallen by 0% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Abera Bioscience AB

Non Operating Income
Highest at SEK 295.58 MM
in the last five periods
MOJO Watch
Increased income from non business activities may not be sustainable

Non Operating income